Literature DB >> 35816211

Hepatocellular Carcinoma in Hemochromatosis: Where or When?

Paul C Adams1.   

Abstract

Entities:  

Year:  2022        PMID： 35816211     DOI： 10.1007/s10620-022-07609-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.487


× No keyword cloud information.
  2 in total

1.  Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes.

Authors:  Yamini Natarajan; Parth Patel; Jinna Chu; Xian Yu; Ruben Hernaez; Hashem El-Serag; Fasiha Kanwal
Journal:  Dig Dis Sci       Date:  2022-07-05       Impact factor: 3.199

2.  Clinical Penetrance of Hereditary Hemochromatosis-Related End-Organ Damage of C282Y Homozygosity, A Newfoundland Experience.

Authors:  Dennis R Lim; Gokul Vidyasankar; Chai Phua; Mark Borgaonkar
Journal:  Clin Transl Gastroenterol       Date:  2020-11       Impact factor: 4.396
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.